CD44

Vigilant Biosciences Launches Clinical Studies of Oral Cancer Assay

Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative...

Save Lives With Simple Oral Cancer Screenings

According to the World Health Organization, there are more than 529,000 new cases of...

Oral Cancer Test Gets European Conformity (CE) Mark

Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer...